Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
263 Farmington Ave
Farmington, CT 06030Phone+1 860-679-3238Fax+1 860-679-1217
Education & Training
Albert Einstein College of MedicineClass of 1971
Certifications & Licensure
CT State Medical License 1983 - 2024
CA State Medical License 1972 - 2018- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (AGAF) American Gastroenterological Association, 2010
- Join now to see all
Clinical Trials
- Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients Start of enrollment: 2005 Nov 01
Publications & Presentations
PubMed
- 44 citationsDurability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis BAnna S. Lok, Fabien Zoulim, Geoffrey Dusheiko, Henry Lik-Yuen Chan, Maria Buti
Hepatology Communications. 2020-01-01 - 62 citationsIntracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes.Naoya Sakamoto, Cathy H. Wu, George Y. Wu
The Journal of Clinical Investigation. 1996-12-15 - 27 citationsDelivery of a Hammerhead Ribozyme Specifically Down-Regulates the Production of Fibrillin-1 by Cultured Dermal FibroblastsMichael W. Kilpatrick, Leonidas A. Phylactou, Maurice Godfrey, Catherine H. Wu, George Y. Wu
Human Molecular Genetics. 1996-12-01
Press Mentions
BPG Is Committed to Discovery and Dissemination of KnowledgeMay 9th, 2005
Grant Support
- Novel Model Of HCV Infection Of Humanized Liver In Immunocompetent RatsNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Targeted Gene Delivery And Expression In HepatocytesNational Institute Of Diabetes And Digestive And Kidney Diseases1994–2005
- Targeted Gene Delivery &Expression In HepatocytesNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1993
- Targeting Of Agents To Normal And Malignant HepatocytesNational Cancer Institute1987–1991
- Targeting To Normal HepatocytesNational Cancer Institute1988–1990
- Receptor-Medicated Chemotherapy For Hepatocellar CarcinoNational Cancer Institute1985–1986
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
